G. Ş. Seçkin Et Al. , "The role of myeloperoxidase G-463A gene polymorphism on the susceptibility and clinicopathological characteristics of bladder cancer," International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) Worldlab , İstanbul, Turkey, 2014
Seçkin, G. Ş. Et Al. 2014. The role of myeloperoxidase G-463A gene polymorphism on the susceptibility and clinicopathological characteristics of bladder cancer. International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) Worldlab , (İstanbul, Turkey).
Seçkin, G. Ş., Küçükgergin, C., Tefik, T. Z., & Şanlı, M. Ö., (2014). The role of myeloperoxidase G-463A gene polymorphism on the susceptibility and clinicopathological characteristics of bladder cancer . International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) Worldlab, İstanbul, Turkey
Seçkin, Güzide Et Al. "The role of myeloperoxidase G-463A gene polymorphism on the susceptibility and clinicopathological characteristics of bladder cancer," International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) Worldlab, İstanbul, Turkey, 2014
Seçkin, Güzide Ş. Et Al. "The role of myeloperoxidase G-463A gene polymorphism on the susceptibility and clinicopathological characteristics of bladder cancer." International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) Worldlab , İstanbul, Turkey, 2014
Seçkin, G. Ş. Et Al. (2014) . "The role of myeloperoxidase G-463A gene polymorphism on the susceptibility and clinicopathological characteristics of bladder cancer." International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) Worldlab , İstanbul, Turkey.
@conferencepaper{conferencepaper, author={Güzide Şule SEÇKİN Et Al. }, title={The role of myeloperoxidase G-463A gene polymorphism on the susceptibility and clinicopathological characteristics of bladder cancer}, congress name={International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) Worldlab}, city={İstanbul}, country={Turkey}, year={2014}}